Israel is and has always been America’s greatest ally, and they continue to prove why.
Hydroxychloroquine sulfate tablets are used against malaria, lupus erythematosus and rheumatoid arthritis but could be effective against COVID-19.
As the coronavirus spreads across the world, and the number of people infected is increasing every day, there is an urgent need to find treatments against COVID-19 that could reduce complications and improve recovery. Recently, Israel’s Health Ministry has approved multiple experimental treatments, and companies worldwide are attempting to determine what could be used to treat the deadly disease.
Teva, the giant Israeli pharmaceutical company, has announced that it will donate more than six million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the United States, starting March 31. Over 10 million tablets are expected to be shipped within a month.
“We are committed to helping to supply as many tablets as possible, as demand for this treatment accelerates, at no cost,” said Brendan O’Grady, Teva executive vice president North America commercial in a statement.
You can read more from our friends at The Jerusalem Post.